[Quantifiable changes in HBeAg expression predict therapeutic efficacy of peg-interferon alfa-2a in patients with HBeAg-positive chronic hepatitis B].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Volumn 21, Issue 5, 2013, Pages 335-339

  Ji, Yong jian ^a   Li, Fei fei ^b   Ren, Wan hua ^b   Zhu, Yu hua ^b   Qin, Cheng yong ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN;

ADULT; BLOOD; FEMALE; HEPATITIS B, CHRONIC; HUMAN; MALE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LAMIVUDINE; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885866669     PISSN: 10073418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)